Caxton Associates (New York)’s Kezar Life Sciences KZR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,177	Closed	-$197K	–	586
2021 Q4	$197K	Buy	+1,177	New	+$197K	0.02%	469